Rare diseases
Investigational molecules
Locations
Back to Germany212 clinical trials in Oldenburg In Holstein, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer
GermanyStudy on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy
GermanyStudy Comparing Repotrectinib and Crizotinib for Patients with Advanced or Metastatic ROS1-positive Non-Small Cell Lung Cancer
GermanyStudy on Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Low-Risk Multiple Myeloma
GermanyStudy on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer
GermanyStudy of Telisotuzumab Vedotin for Adults with Advanced Non-Squamous Non-Small Cell Lung Cancer
GermanyStudy to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy Comparing DZD9008 and Chemotherapy for First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Mutation
GermanyStudy Comparing Atezolizumab and Drug Combination with Pembrolizumab and Drug Combination for Patients with Advanced Lung Cancer
GermanyEvaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk
GermanyStudy on the Effects of AZD5004 for Adults with Obesity or Overweight and a Related Medical Condition
GermanyStudy Comparing Carboplatin and Cisplatin for Patients with Extracranial Malignant Germ Cell Tumors
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on Type 2 Diabetes management and treatments, including studies of novel weekly insulin alternatives and oral medications for glycemic control.
Multiple studies evaluating new therapeutic approaches for better diabetes management and reducing cardiovascular risks.
Comprehensive research into obesity treatment and weight-related conditions, examining new therapeutic combinations and their effects on weight loss and associated health conditions.
Studies focusing on innovative approaches to weight management and treating obesity-related health complications.
Research examining treatments for atherosclerotic cardiovascular disease and related conditions, with emphasis on preventing major adverse cardiovascular events.
Trials evaluating new medications for improving cardiovascular outcomes in high-risk patients.
Clinical investigations of treatments for Crohn's Disease and other digestive conditions, focusing on long-term efficacy and safety of new therapeutic approaches.
Studies aimed at improving quality of life for patients with chronic gastrointestinal conditions.
Advanced studies in colorectal cancer treatment and management, including innovative approaches to Stage II and III cancer therapy.
Trials evaluating new treatment strategies for improving outcomes in cancer patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
